Used as a key chiral building block in the synthesis of fluorinated pharmaceuticals, particularly in the development of protease inhibitors and other bioactive molecules. The difluorinated pyrrolidine structure enhances metabolic stability and membrane permeability, making it valuable in medicinal chemistry. The Fmoc (fluorenylmethyloxycarbonyl) group allows for solid-phase peptide synthesis, enabling incorporation into peptides with stereochemical control. Commonly applied in research settings for creating peptidomimetics and targeted drug candidates, especially in oncology and antiviral therapy.